Allergan Plc (AGN)
$163.88 1.45 (0.89%)
7:07 EDT AGN Stock Quote Delayed 15 Minutes
Previous Close $162.43
Market Cap 64.31B
PE Ratio -31.95
Volume (Avg. Vol.) 247
Day's Range 162.33 - 168.65
52-Week Range 114.27 - 197.00
Dividend & Yield 2.88 (1.76%)
AGN Stock Predictions, Articles, and Allergan Plc News
- From InvestorPlace
- From the Web
Biotech rallied on a $63 billion deal between AbbVie and Allergan. But other than that, it was a tough day for the Nasdaq today.
AbbVie is buying Allergan, FedEx and Blackberry are reporting earnings and Microsoft is on the move. Here are our top stock trades.
News of an AbbVie-Allergan deal has AGG stock heading higher on Tuesday with plans for the former company to acquire the latter.
Allergan looks to still be in a downtrend, while Etsy stock is fighting with resistance at $70 and Boeing hurdles the 50-day moving average.
The stock charts of Centurylink, Allergan and Charles Schwab are prepared to get the new trading week started with a bang.
Wall Street analysts see significant upside in these 10 stocks to buy. And all ten have other reasons for optimism as well.
Government is scrutinizing the drug development and approval process and creating uncertainties among biotech stocks. Time to buy?
Realty Income, Allergan, Boeing, Mylan and the S&P 500 were big movers on Tuesday. You have to see these must-see stock charts.
Allergen needs to win back investors as the company continues to look for new drug products. AGN stock is stuck in a narrow trading range.
Not all stocks are lifted by a rising tide, especially these blue-chip stocks that look like they're in for some trouble.
AMZN, TAP, ALGN and AGN are just some of the stocks on the rise as we head into the second quarter of the year.
As Goldman Sachs moves away from the strong balance sheet investing strategy, here are 6 new stocks to buy.
Biotech stocks offer more than just capital gains; some of them pay dividends. Here are three dividend-paying biotechs to consider.
Don't ignore Dow Jones stocks. They can still power your portfolio. Here are 5 of the best to own in 2019 and beyond!
Pharmaceutical stocks have been on the rebound and many are raising their prices this year. What does that mean for business?
AGN stock is taking a beating today on some bad news about Allergan's breast implants and concerns over links to cancer.
From Seeking Alpha
From Wall Street Journal
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!